Global Veterinary Vaccines Market Size, Trends, and Growth Opportunity, By Vaccine Type (Livestock Vaccines and Companion Animal Vaccines), By Disease (Porcine, Poultry, Livestock, Companion Animals, Aquaculture), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Others), By Region and Forecast to 2030.
Global Veterinary Vaccines Market
The Global Veterinary Vaccines Market was valued at USD 9.5 billion in 2022 and is expected to expand to USD 18.91 billion by 2030, at a CAGR of 7.9% during the forecast period 2023-2030.
Veterinary vaccines prevent diseases that pass between animals and from animals to humans. Diseases prevalent in wildlife, such as distemper and rabies, can infect unvaccinated pets. These vaccinations protect animals from various contagious diseases such as parvovirus & respiratory tract infections. It also protects pets against transmissible diseases that also pose a risk to humans.
Market Drivers
The increase in cattle disease outbreaks and the growing livestock population are some of the major factors for the huge acceptance of ruminants, particularly cattle vaccines. These factors drive the demand for the global veterinary vaccines market.
Furthermore, a vast number of research activities have been done for the betterment of the veterinary vaccines market growth. Also, the growing demand for attenuated live vaccines and the increase in the demand for intranasal administration factors help in the market growth.
Market Restraints
Various side effects relate to veterinary animal vaccine products. Some of the basic effects are local swelling and discomfort at the vaccination site, low appetite and activity, mild fever, a snotty nose, sneezing, and severe coughing. Thus, all these factors impede the global veterinary vaccines market growth.
Market Segmentation
The global veterinary vaccines market is segmented into vaccine type, disease, technology, and region.
Based on the vaccine type, the global veterinary vaccines market is segmented into livestock vaccines and companion animal vaccines.
Further, based on technology, the market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others.
Regional Analysis
The global veterinary vaccines market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the global veterinary vaccines market due to growing occurrences of zoonotic diseases and livestock, resulting in many animal deaths in this region. Furthermore, the rise in animal health expenditure and the wide presence of renowned pharmaceutical companies increase the market's growth rate in the region.
Key Players
Various key players are discussed in the global veterinary vaccines market report including; Zoetis Inc., Merck & Co. Inc., Virbac, Hester Biosciences Limited, Elanco Animal Health, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Phibro Animal Health Corporation, HIPRA, Indovax, and Others.
For instance, in 2021, Boehringer Ingelheim launched a single-shot poultry vaccine, ‘VAXXITEK HVT+IBD’. The vaccine is a novel recombinant that offers lifelong protection for all producing chickens. It protects against 2 important immunosuppressive diseases such as IBD and Marek's Disease.
Market Taxonomy
By Vaccine Type
• Livestock Vaccines
• Companion Animal Vaccines
By Disease
• Porcine
• Poultry
• Livestock
• Companion Animals
• Aquaculture
By Technology
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Veterinary Vaccines Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Veterinary Vaccines Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact Of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Veterinary Vaccines Market, By Vaccine Type
5.1 Y-o-Y Growth Comparison, By Vaccine Type
5.2 Global Veterinary Vaccines Market Share Analysis, By Vaccine Type
5.3 Global Veterinary Vaccines Market Size and Forecast, By Vaccine Type
5.3.1 Livestock Vaccines
5.3.2 Companion Animal Vaccines
6 Global Veterinary Vaccines Market, By Disease
6.1 Y-o-Y Growth Comparison, By Disease
6.2 Global Veterinary Vaccines Market Share Analysis, By Disease
6.3 Global Veterinary Vaccines Market Size and Forecast, By Disease
6.3.1 Porcine
6.3.2 Poultry
6.3.3 Livestock
6.3.4 Companion Animals
6.3.5 Aquaculture
7 Global Veterinary Vaccines Market, By Technology
7.1 Y-o-Y Growth Comparison, By Technology
7.2 Global Veterinary Vaccines Market Share Analysis, By Technology
7.3 Global Veterinary Vaccines Market Size and Forecast, By Technology
7.3.1 Live-Attenuated Vaccines
7.3.2 Inactivated Vaccines
7.3.3 Toxoid Vaccines
7.3.4 Recombinant Vaccines
7.3.5 Others
8 Global Veterinary Vaccines Market, By Region
8.1 Global Veterinary Vaccines Market Share Analysis, By Region
8.2 Global Veterinary Vaccines Market Share Analysis, By Region
8.3 Global Veterinary Vaccines Market Size and Forecast, By Region
9 North America Veterinary Vaccines Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Veterinary Vaccines Market Share Analysis, By Vaccine Type
9.3 North America Veterinary Vaccines Market Share Analysis, By Disease
9.4 North America Veterinary Vaccines Market Size and Forecast, By Technology
9.5 North America Veterinary Vaccines Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Veterinary Vaccines Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Veterinary Vaccines Market Share Analysis, By Vaccine Type
10.3 Europe Veterinary Vaccines Market Share Analysis, By Disease
10.4 Europe Veterinary Vaccines Market Size and Forecast, By Technology
10.5 Europe Veterinary Vaccines Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Veterinary Vaccines Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Veterinary Vaccines Market Share Analysis, By Vaccine Type
11.3 Asia Pacific Veterinary Vaccines Market Share Analysis, By Disease
11.4 Asia Pacific Veterinary Vaccines Market Size and Forecast, By Technology
11.5 Asia Pacific Veterinary Vaccines Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Veterinary Vaccines Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Veterinary Vaccines Market Share Analysis, By Vaccine Type
12.3 Latin America Veterinary Vaccines Market Share Analysis, By Disease
12.4 Latin America Veterinary Vaccines Market Size and Forecast, By Technology
12.5 Latin America Veterinary Vaccines Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Veterinary Vaccines Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Veterinary Vaccines Market Share Analysis, By Vaccine Type
13.3 Middle East Veterinary Vaccines Market Share Analysis, By Disease
13.4 Middle East Veterinary Vaccines Market Size and Forecast, By Technology
13.5 Middle East Veterinary Vaccines Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market Share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Zoetis Inc.
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Merck & Co. Inc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.25 Key Market Developments
15.2.6 Key Strategies
15.3 Virbac
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Hester Biosciences Limited
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Elanco Animal Health
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Boehringer Ingelheim International GmbH
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Ceva Sante Animale
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Phibro Animal Health Corporation
15. 8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 HIPRA
15.9.1 Overview
15.9.2 Offerings
15.4.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Indovax
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
